{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:28:22Z","timestamp":1793089702617,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbrep.2025.102034","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T20:29:32Z","timestamp":1745872172000},"page":"102034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["SLC16A3 (MCT4) expression in tumor immunity and Metabolism: Insights from pan-cancer analysis"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5131-8707","authenticated-orcid":false,"given":"Wenxing","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrep.2025.102034_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl 6","key":"10.1016\/j.bbrep.2025.102034_bib2","doi-asserted-by":"crossref","first-page":"S577","DOI":"10.21037\/tcr.2019.05.24","article-title":"Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma","volume":"8","author":"Mitchell","year":"2019","journal-title":"Transl. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102034_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031454","article-title":"Breakthrough in blastic plasmacytoid dendritic cell neoplasm cancer therapy owing to precision targeting of CD123","volume":"25","author":"Zanotta","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102034_bib4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.21037\/tlcr.2018.09.22","article-title":"Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapy","volume":"7","author":"Hendriks","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102034_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","article-title":"Lactate modulation of immune responses in inflammatory versus tumour microenvironments","volume":"21","author":"Certo","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102034_bib6","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"issue":"42","key":"10.1016\/j.bbrep.2025.102034_bib7","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1038\/onc.2017.188","article-title":"Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells","volume":"36","author":"Feng","year":"2017","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102034_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"issue":"16","key":"10.1016\/j.bbrep.2025.102034_bib9","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41388-020-1216-5","article-title":"The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment","volume":"39","author":"Brown","year":"2020","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102034_bib10","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.4049\/jimmunol.1700604","article-title":"GPR81, a cell-surface receptor for lactate, regulates intestinal homeostasis and protects mice from experimental colitis","volume":"200","author":"Ranganathan","year":"2018","journal-title":"J. Immunol."},{"issue":"7779","key":"10.1016\/j.bbrep.2025.102034_bib11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bbrep.2025.102034_bib12","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1172\/JCI128644","article-title":"Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment","volume":"129","author":"Petty","year":"2019","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102034_bib13","first-page":"1885","article-title":"M2-TAM subsets altered by lactic acid promote T-cell apoptosis through the PD-L1\/PD-1 pathway","volume":"44","author":"Shan","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrep.2025.102034_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107451","article-title":"Lactate\/GPR81 signaling and proton motive force in cancer: role in angiogenesis, immune escape, nutrition, and Warburg phenomenon","volume":"206","author":"Brown","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"13","key":"10.1016\/j.bbrep.2025.102034_bib15","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1158\/0008-5472.CAN-18-3726","article-title":"The tumor metabolic microenvironment: lessons from lactate","volume":"79","author":"Garcia-Canaveras","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2025.102034_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","article-title":"Monocarboxylate transporters in cancer","volume":"33","author":"Payen","year":"2020","journal-title":"Mol. Metabol."},{"issue":"52","key":"10.1016\/j.bbrep.2025.102034_bib17","doi-asserted-by":"crossref","first-page":"20135","DOI":"10.1074\/jbc.RA119.009093","article-title":"Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments","volume":"294","author":"Contreras-Baeza","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102034_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1158\/0008-5472.CAN-14-2260","article-title":"Genetic disruption of lactate\/H+ symporters (MCTs) and their subunit CD147\/BASIGIN sensitizes glycolytic tumor cells to phenformin","volume":"75","author":"Marchiq","year":"2015","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102034_bib19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1158\/1535-7163.MCT-17-0535","article-title":"MCT4 expression is a potential therapeutic target in colorectal cancer with peritoneal carcinomatosis","volume":"17","author":"Kim","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"issue":"11","key":"10.1016\/j.bbrep.2025.102034_bib20","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1002\/cam4.1521","article-title":"Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy","volume":"7","author":"Chen","year":"2018","journal-title":"Cancer Med."},{"issue":"10","key":"10.1016\/j.bbrep.2025.102034_bib21","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ejso.2014.04.005","article-title":"Stromal-epithelial metabolic coupling in gastric cancer: stromal MCT4 and mitochondrial TOMM20 as poor prognostic factors","volume":"40","author":"Zhao","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.bbrep.2025.102034_bib22","first-page":"187","article-title":"MCT4 promotes cell proliferation and invasion of castration-resistant prostate cancer PC-3 cell line","volume":"18","author":"Sun","year":"2019","journal-title":"EXCLI J"},{"key":"10.1016\/j.bbrep.2025.102034_bib23","article-title":"Integrative analysis identified MCT4 as an independent prognostic factor for bladder cancer","volume":"11","author":"Zhao","year":"2021","journal-title":"Front. Oncol."},{"issue":"7391","key":"10.1016\/j.bbrep.2025.102034_bib24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.bbrep.2025.102034_bib25","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2025.102034_bib26","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bbrep.2025.102034_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108717","article-title":"Evolution of resistance to irinotecan in cancer cells involves generation of topoisomerase-guided mutations in non-coding genome that reduce the chances of DNA breaks","volume":"24","author":"Kumar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bbrep.2025.102034_bib28","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s11864-023-01143-7","article-title":"Application of engineered dendritic cell vaccines in cancer immunotherapy: challenges and opportunities","volume":"24","author":"Li","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.bbrep.2025.102034_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1135489","article-title":"Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy","volume":"14","author":"Sadeghirad","year":"2023","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbrep.2025.102034_bib30","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","article-title":"The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression","volume":"95","author":"Vaupel","year":"2019","journal-title":"Int. J. Radiat. Biol."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102034_bib31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrep.2025.102034_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100797","article-title":"Impact of cancer metabolism on therapy resistance - clinical implications","volume":"59","author":"Goncalves","year":"2021","journal-title":"Drug Resist. Updates"},{"issue":"3","key":"10.1016\/j.bbrep.2025.102034_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbrep.2025.102034_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1091779","article-title":"The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrep.2025.102034_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216824","article-title":"Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming","volume":"589","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrep.2025.102034_bib36","doi-asserted-by":"crossref","first-page":"8413","DOI":"10.2147\/IJGM.S337615","article-title":"Prognostic value of slc16a3(MCT4) in lung adenocarcinoma and its clinical significance","volume":"14","author":"Xue","year":"2021","journal-title":"Int. J. Gen. Med."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102034_bib37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/19336950.2021.1965422","article-title":"A pan-cancer analysis revealed the role of the SLC16 family in cancer","volume":"15","author":"Li","year":"2021","journal-title":"Channels"},{"key":"10.1016\/j.bbrep.2025.102034_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150709","article-title":"Knockdown of SLC16A3 decreases extracellular lactate concentration in hepatocellular carcinoma, alleviates hypoxia and induces ferroptosis","volume":"733","author":"Shen","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.bbrep.2025.102034_bib39","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Martinez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bbrep.2025.102034_bib40","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1113\/JP278810","article-title":"Revisiting the Warburg effect: historical dogma versus current understanding","volume":"599","author":"Vaupel","year":"2021","journal-title":"J. Physiol."},{"issue":"10","key":"10.1016\/j.bbrep.2025.102034_bib41","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/cac2.12348","article-title":"Pivotal roles of tumor-draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy","volume":"42","author":"Liu","year":"2022","journal-title":"Cancer Commun."},{"issue":"12","key":"10.1016\/j.bbrep.2025.102034_bib42","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00011-023-01807-y","article-title":"Targeting glycolytic pathway in fibroblast-like synoviocytes for rheumatoid arthritis therapy: challenges and opportunities","volume":"72","author":"Li","year":"2023","journal-title":"Inflamm. Res."},{"issue":"8","key":"10.1016\/j.bbrep.2025.102034_bib43","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1158\/0008-5472.CAN-20-3044","article-title":"HDAC11 regulates glycolysis through the LKB1\/AMPK signaling pathway to maintain hepatocellular carcinoma stemness","volume":"81","author":"Bi","year":"2021","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102034_bib44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41419-021-03596-w","article-title":"The fatty acid receptor CD36 promotes HCC progression through activating Src\/PI3K\/AKT axis-dependent aerobic glycolysis","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrep.2025.102034_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1013885","article-title":"Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy","volume":"10","author":"Xiao","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102034_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100551","article-title":"Sulconazole induces PANoptosis by triggering oxidative stress and inhibiting glycolysis to increase radiosensitivity in esophageal cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cell. Proteomics"},{"issue":"6","key":"10.1016\/j.bbrep.2025.102034_bib47","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2016.10.006","article-title":"Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy","volume":"30","author":"Cantelmo","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrep.2025.102034_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216696","article-title":"Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy","volume":"587","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrep.2025.102034_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216657","article-title":"Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer","volume":"587","author":"Zhao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrep.2025.102034_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216285","article-title":"NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma","volume":"567","author":"Chen","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102034_bib51","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.canlet.2015.05.015","article-title":"Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells","volume":"365","author":"Amorim","year":"2015","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102034_bib52","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1038\/s41467-019-10566-6","article-title":"Mechanistic basis of L-lactate transport in the SLC16 solute carrier family","volume":"10","author":"Bosshart","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102034_bib53","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ijc.31812","article-title":"Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase","volume":"144","author":"Golias","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"19","key":"10.1016\/j.bbrep.2025.102034_bib54","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1074\/jbc.RA118.006095","article-title":"Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis","volume":"294","author":"Hong","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102034_bib55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-024-02008-9","article-title":"Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"issue":"46","key":"10.1016\/j.bbrep.2025.102034_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi8602","article-title":"Lactate supports a metabolic-epigenetic link in macrophage polarization","volume":"7","author":"Noe","year":"2021","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102034_bib57","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41419-021-03648-1","article-title":"Down-regulation of SLC25A20 promotes hepatocellular carcinoma growth and metastasis through suppression of fatty-acid oxidation","volume":"12","author":"Yuan","year":"2021","journal-title":"Cell Death Dis."},{"issue":"7919","key":"10.1016\/j.bbrep.2025.102034_bib58","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04898-5","article-title":"Mitochondrial RNA modifications shape metabolic plasticity in metastasis","volume":"607","author":"Delaunay","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102034_bib59","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","article-title":"Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity","volume":"13","author":"Feng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrep.2025.102034_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cytogfr.2022.11.001","article-title":"Crosstalk between glucose metabolism, lactate production and immune response modulation","volume":"68","author":"Ye","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbrep.2025.102034_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2022.1610350","article-title":"Cancer-associated stromal fibroblast-derived transcriptomes predict poor clinical outcomes and immunosuppression in colon cancer","volume":"28","author":"Wang","year":"2022","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.bbrep.2025.102034_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.641978","article-title":"Evaluation of monocarboxylate transporter 4 (MCT4) expression and its prognostic significance in circulating tumor cells from patients with early stage non-small-cell lung cancer","volume":"9","author":"Markou","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrep.2025.102034_bib63","article-title":"MCT4 promotes tumor malignancy in F98 glioma cells","volume":"2021","author":"Reuss","year":"2021","journal-title":"JAMA Oncol."},{"issue":"33","key":"10.1016\/j.bbrep.2025.102034_bib64","doi-asserted-by":"crossref","first-page":"20159","DOI":"10.1073\/pnas.1918986117","article-title":"ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102034_bib65","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.32348","article-title":"Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack","volume":"77","author":"Fang","year":"2023","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.bbrep.2025.102034_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007349","article-title":"MCT4 blockade increases the efficacy of immune checkpoint blockade","volume":"11","author":"Babl","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"3","key":"10.1016\/j.bbrep.2025.102034_bib67","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/cai2.32","article-title":"Prognostic value of lactate transporter SLC16A1 and SLC16A3 as oncoimmunological biomarkers associating tumor metabolism and immune evasion in glioma","volume":"1","author":"Zhu","year":"2022","journal-title":"Cancer Innov"},{"key":"10.1016\/j.bbrep.2025.102034_bib68","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.2147\/IJGM.S353592","article-title":"Lactate transporter SLC16A3 (MCT4) as an onco-immunological biomarker associating tumor microenvironment and immune responses in lung cancer","volume":"15","author":"Tao","year":"2022","journal-title":"Int. J. Gen. Med."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102034_bib69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.alit.2022.01.001","article-title":"Immune-related adverse events in various organs caused by immune checkpoint inhibitors","volume":"71","author":"Okiyama","year":"2022","journal-title":"Allergol. Int."},{"issue":"Pt 3","key":"10.1016\/j.bbrep.2025.102034_bib70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcancer.2022.03.014","article-title":"Immune checkpoint proteins: signaling mechanisms and molecular interactions in cancer immunotherapy","volume":"86","author":"Gaikwad","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"10","key":"10.1016\/j.bbrep.2025.102034_bib71","article-title":"Different lactate metabolism subtypes reveal heterogeneity in clinical outcomes and immunotherapy in lung adenocarcinoma patients","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrep.2025.102034_bib72","article-title":"Neoantigen cancer vaccines and different immune checkpoint therapies each utilize both converging and distinct mechanisms that in combination enable synergistic therapeutic efficacy","author":"Keshari","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbrep.2025.102034_bib73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.humpath.2020.04.003","article-title":"Programmed death ligand 1\/indoleamine 2,3-dioxygenase 1 expression and tumor-infiltrating lymphocyte status in renal cell carcinoma with sarcomatoid changes and rhabdoid features","volume":"101","author":"Kiyozawa","year":"2020","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102034_bib74","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41591-020-0860-1","article-title":"High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade","volume":"26","author":"Yuen","year":"2020","journal-title":"Nat. Med."},{"issue":"25","key":"10.1016\/j.bbrep.2025.102034_bib75","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1056\/NEJMoa1613493","article-title":"First-Line nivolumab in stage IV or recurrent non-small-cell lung cancer","volume":"376","author":"Carbone","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7399","key":"10.1016\/j.bbrep.2025.102034_bib76","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature11071","article-title":"Melanoma genome sequencing reveals frequent PREX2 mutations","volume":"485","author":"Berger","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbrep.2025.102034_bib77","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3389\/fimmu.2020.01280","article-title":"Cancer stem cells-origins and biomarkers: perspectives for targeted personalized therapies","volume":"11","author":"Walcher","year":"2020","journal-title":"Front. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.bbrep.2025.102034_bib78","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","article-title":"The SLC16 gene family - structure, role and regulation in health and disease","volume":"34","author":"Halestrap","year":"2013","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.bbrep.2025.102034_bib79","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2142\/biophysico.15.0_94","article-title":"iMusta4SLC: database for the structural property and variations of solute carrier transporters","volume":"15","author":"Higuchi","year":"2018","journal-title":"Biophys Physicobiol"},{"issue":"4","key":"10.1016\/j.bbrep.2025.102034_bib80","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00424-023-02876-y","article-title":"What can we learn about acid-base transporters in cancer from studying somatic mutations in their genes?","volume":"476","author":"White","year":"2024","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102034_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73951-y","article-title":"Analysis of microRNA-34a expression profile and rs2666433 variant in colorectal cancer: a pilot study","volume":"10","author":"Fawzy","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102034_bib82","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.3892\/ol.2017.6444","article-title":"MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling","volume":"14","author":"Zhang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrep.2025.102034_bib83","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbrc.2021.01.047","article-title":"Alternative regulation of HIF-1alpha stability through phosphorylation on Ser451","volume":"545","author":"Han","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"41","key":"10.1016\/j.bbrep.2025.102034_bib84","doi-asserted-by":"crossref","first-page":"31277","DOI":"10.1074\/jbc.M110.158485","article-title":"Stabilization of hypoxia-inducible factor-1alpha protein in hypoxia occurs independently of mitochondrial reactive oxygen species production","volume":"285","author":"Chua","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102034_bib85","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1021\/acs.jproteome.5b00503","article-title":"Acidosis-induced changes in proteome patterns of the prostate cancer-derived tumor cell line AT-1","volume":"14","author":"Ihling","year":"2015","journal-title":"J. Proteome Res."},{"issue":"11","key":"10.1016\/j.bbrep.2025.102034_bib86","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.7150\/ijms.46034","article-title":"Cancer cell enters reversible quiescence through intracellular acidification to resist paclitaxel cytotoxicity","volume":"17","author":"Jia","year":"2020","journal-title":"Int. J. Med. Sci."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825001219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825001219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:17:07Z","timestamp":1749035827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825001219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":86,"alternative-id":["S2405580825001219"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102034","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SLC16A3 (MCT4) expression in tumor immunity and Metabolism: Insights from pan-cancer analysis","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102034"}}